Pharmaceutical packaging and delivery systems producer West Pharmaceutical Services is planning to open a new production site in Waterford, Ireland, in a move to expand its global manufacturing operations.
The proposed plant will produce packaging components for insulin injector cartridges and other high-value packaging components, in order to meet growing demand from pharmaceutical and biotech customers.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Construction on the plant will begin in early 2015 after the company receives planning and zoning approvals for the project.
Upon completion, the plant will be a centre of excellence for West Pharmaceutical Services’ proprietary elastomeric sheeting, which is used to package insulin for use in pen injectors.
West Pharmaceutical Services chairman and CEO Donald E. Morel, Jr. said: "With diabetes emerging as one of the fastest-growing diseases globally, our pharmaceutical customers are expanding their production lines for injectable insulin.
"To meet this growing demand, we are announcing an expansion today that will help us address this need and continue to serve this critical patient population.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"In the future, we intend for this site to be a centre of excellence for advanced packaging components to meet the needs of our customer base for a range of sophisticated injectable therapies."
West Pharmaceutical Services also plans to expand manufacturing space for injectable component product lines in the future.
Further expansions at the plant will see around €100m in investment.
Expansion at West Pharmaceutical Services’ Mulhuddart facility in Dublin is currently underway.
